Pfizer registers 62 percent growth in CDO services
07 July 2005 | News
Pfizer Ltd has registered a growth of 62 percent in the clinical development
operations (CDO) services during the quarter ended May 31, 2005. The company has
recorded revenue of Rs 6.64 crore from this service for quarter ending May 31,
2005 as against Rs 4.09 crore in the corresponding period last year. Pfizer has
maintained a growth of 65 percent in clinical development operations during the
first half of its financial year recording Rs 11.55 crore in revenues, an
increase of Rs 4.56 crore over the corresponding period last year.
